IgA itself represents the first line of defence against mucosally-invasive bacteria, and individuals with IgA nephropathy have increased levels of the galactose-deficient form of IgA14, as well as glycan-specific autoantibodies5. The gene discussed is CD79A; the disease is IgA glomerulonephritis.